The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis

Recognizing the robust sex differences in schizophrenia prevalence, the selective estrogen receptor modulator (SERM) raloxifene is a likely candidate for augmentation therapy in this disorder. Therefore, a systematic search was performed using PubMed (Medline), Embase, PsychInfo, and Cochrane Databa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:NPJ Schizophr
Main Authors: de Boer, Janna, Prikken, Merel, Lei, Wan U., Begemann, Marieke, Sommer, Iris
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2018
Teme:
Review Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5762671/
https://ncbi.nlm.nih.gov/pubmed/29321530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41537-017-0043-3
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki